Connection

AYSEGUL A SAHIN to Carcinoma

This is a "connection" page, showing publications AYSEGUL A SAHIN has written about Carcinoma.
Connection Strength

1.912
  1. Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit. Semin Diagn Pathol. 2022 Sep; 39(5):313-321.
    View in: PubMed
    Score: 0.360
  2. High-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates. Surg Pathol Clin. 2022 Mar; 15(1):77-93.
    View in: PubMed
    Score: 0.355
  3. Nuclear staining for pan-Trk by immunohistochemistry is highly specific for secretory carcinoma of breast: pan-Trk in various subtypes of breast carcinoma. J Clin Pathol. 2024 Oct 20; 77(11):751-755.
    View in: PubMed
    Score: 0.107
  4. Expression of c-kit proto-oncogene product in breast tissue. Breast J. 2004 Jul-Aug; 10(4):323-7.
    View in: PubMed
    Score: 0.105
  5. A Comparative Evaluation of TRPS1 and GATA3 in adenoid cystic, secretory, and acinic cell carcinomas of the breast and salivary gland. Hum Pathol. 2024 03; 145:42-47.
    View in: PubMed
    Score: 0.102
  6. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features. Cancer. 2003 Sep 01; 98(5):1055-60.
    View in: PubMed
    Score: 0.099
  7. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol. 2022 03; 121:73-80.
    View in: PubMed
    Score: 0.089
  8. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol. 2021 04; 34(4):710-719.
    View in: PubMed
    Score: 0.081
  9. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000 Sep; 24(9):1266-72.
    View in: PubMed
    Score: 0.080
  10. Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol. 2000 May; 7(3):158-66.
    View in: PubMed
    Score: 0.079
  11. Phyllodes tumours of the breast: a consensus review. Histopathology. 2016 Jan; 68(1):5-21.
    View in: PubMed
    Score: 0.058
  12. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2003 Feb 01; 97(3):715-7; author reply 717.
    View in: PubMed
    Score: 0.048
  13. Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol. 2007 Dec; 15(4):451-5.
    View in: PubMed
    Score: 0.033
  14. Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer. 2006 Nov 01; 107(9):2245-53.
    View in: PubMed
    Score: 0.031
  15. Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy. Cancer. 2006 Mar 01; 106(5):1000-6.
    View in: PubMed
    Score: 0.029
  16. The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study. Cancer. 2005 Jul 15; 104(2):229-35.
    View in: PubMed
    Score: 0.028
  17. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer. 2005 Apr 01; 103(7):1323-9.
    View in: PubMed
    Score: 0.028
  18. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res Treat. 2005 Jan; 89(2):99-105.
    View in: PubMed
    Score: 0.027
  19. Breast carcinoma with choriocarcinomatous features. Ann Diagn Pathol. 2004 Apr; 8(2):74-9.
    View in: PubMed
    Score: 0.026
  20. STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis. Cancer. 2004 Jan 01; 100(1):12-9.
    View in: PubMed
    Score: 0.025
  21. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer. 2002 Aug 25; 96(4):225-31.
    View in: PubMed
    Score: 0.023
  22. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast. Ann Diagn Pathol. 2002 06; 6(3):141-7.
    View in: PubMed
    Score: 0.023
  23. Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections. Breast Cancer Res Treat. 1996; 39(2):177-85.
    View in: PubMed
    Score: 0.015
  24. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Res. 2014; 16(6):3417.
    View in: PubMed
    Score: 0.013
  25. Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum Pathol. 1993 Nov; 24(11):1203-10.
    View in: PubMed
    Score: 0.013
  26. Sarcomatoid carcinoma of the lung. Immunohistochemical and ultrastructural studies of 14 cases. Cancer. 1992 Jan 15; 69(2):376-86.
    View in: PubMed
    Score: 0.011
  27. Chromosome in situ hybridization on formalin-fixed mammary tissue using non-isotopic, non-fluorescent probes: technical considerations and biological implications. Breast Cancer Res Treat. 1992; 23(3):201-10.
    View in: PubMed
    Score: 0.011
  28. Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung. Cancer. 1990 Feb 01; 65(3):530-7.
    View in: PubMed
    Score: 0.010
  29. Correlation of p27 protein expression with HER-2/neu expression in breast cancer. Mol Carcinog. 2001 Mar; 30(3):169-75.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.